Literature DB >> 21388344

Use of DAF-displaying adenovirus vectors reduces induction of transgene- and vector-specific adaptive immune responses in mice.

Sergey S Seregin1, Yasser A Aldhamen, Daniel M Appledorn, Jennifer Zehnder, Tyler Voss, Sarah Godbehere, Andrea Amalfitano.   

Abstract

Adenovirus (Ad)-based vectors are attractive candidates for a variety of gene-transfer applications. In this study, we found that decay-accelerating factor (DAF)-displaying Ads induce significantly decreased cellular immune responses to transgenes expressed from the vectors in both Ad5-naive and Ad5-immune mice. Specifically, we found a diminished ability of splenocytes to secrete interferon-γ after recall exposure to multiple peptides derived from antigens expressed by DAF-displaying Ads. We also confirmed that DAF-displaying Ads induce decreased numbers of antigen-specific, CD8(+) effector memory and central memory CD8(+) T cells, thereby uncovering a unique role of complement in modulating the induction of robust memory T-cell responses. We also confirmed that DAF-displaying Ads generate significantly reduced titers of Ad capsid-specific neutralizing antibodies after gene transfer in vivo. In conclusion, DAF-displaying Ad5-based vectors exhibit decreased induction of complement-dependent, innate immune responses, resulting in both an improved safety profile and a decreased propensity to induce humoral and cellular adaptive immune responses to Ad capsid proteins and Ad vector-expressed transgene products. This attractive combination of features will be beneficial in a variety of clinically relevant gene-transfer applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388344      PMCID: PMC3177950          DOI: 10.1089/hum.2010.218

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  49 in total

1.  Construction of first-generation adenoviral vectors.

Authors:  Philip Ng; Frank L Graham
Journal:  Methods Mol Med       Date:  2002

Review 2.  Strategies of therapeutic complement inhibition.

Authors:  Tom E Mollnes; Michael Kirschfink
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

Review 3.  Complement and Toll-like receptors: key regulators of adaptive immune responses.

Authors:  Heiko Hawlisch; Jörg Köhl
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

4.  Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo.

Authors:  Zachary C Hartman; Anne Kiang; Ruth S Everett; Delila Serra; Xiao Y Yang; Timothy M Clay; Andrea Amalfitano
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

Review 5.  Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.

Authors:  Zachary C Hartman; Daniel M Appledorn; Andrea Amalfitano
Journal:  Virus Res       Date:  2007-11-26       Impact factor: 3.303

Review 6.  Immune responses to adeno-associated virus vectors.

Authors:  Anne K Zaiss; Daniel A Muruve
Journal:  Curr Gene Ther       Date:  2005-06       Impact factor: 4.391

7.  Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy.

Authors:  Sergey S Seregin; Daniel M Appledorn; Aaron J McBride; Nathaniel J Schuldt; Yasser A Aldhamen; Tyler Voss; Junping Wei; Matthew Bujold; William Nance; Sarah Godbehere; Andrea Amalfitano
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

Review 8.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

9.  Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection.

Authors:  M Suresh; Hector Molina; Maria S Salvato; Dimitrios Mastellos; John D Lambris; Matyas Sandor
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

10.  Protective immune responses against West Nile virus are primed by distinct complement activation pathways.

Authors:  Erin Mehlhop; Michael S Diamond
Journal:  J Exp Med       Date:  2006-05-01       Impact factor: 14.307

View more
  6 in total

1.  Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy.

Authors:  Yasser A Aldhamen; Sergey S Seregin; Charles F Aylsworth; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2013-12-27       Impact factor: 4.823

2.  Adenovirus-based vaccination against Clostridium difficile toxin A allows for rapid humoral immunity and complete protection from toxin A lethal challenge in mice.

Authors:  Sergey S Seregin; Yasser A Aldhamen; David P W Rastall; Sarah Godbehere; Andrea Amalfitano
Journal:  Vaccine       Date:  2011-12-23       Impact factor: 3.641

3.  Stimulation of innate immunity by in vivo cyclic di-GMP synthesis using adenovirus.

Authors:  Benjamin J Koestler; Sergey S Seregin; David P W Rastall; Yasser A Aldhamen; Sarah Godbehere; Andrea Amalfitano; Christopher M Waters
Journal:  Clin Vaccine Immunol       Date:  2014-09-17

4.  Schistosoma mansoni soluble egg antigens enhance T cell responses to a newly identified HIV-1 Gag H-2b epitope.

Authors:  Cac T Bui; Lisa M Shollenberger; Yvonne Paterson; Donald A Harn
Journal:  Clin Vaccine Immunol       Date:  2014-12-17

5.  Innate Immune Responses to AAV Vectors.

Authors:  Geoffrey L Rogers; Ashley T Martino; George V Aslanidi; Giridhara R Jayandharan; Arun Srivastava; Roland W Herzog
Journal:  Front Microbiol       Date:  2011-09-19       Impact factor: 5.640

6.  Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.

Authors:  Yasser Ali Aldhamen; Sergey S Seregin; Andrea Amalfitano
Journal:  Front Immunol       Date:  2011-09-06       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.